Sofinno­va, For­bion back $70M push across fin­ish line for rare an­ti­fun­gal treat­ment

As the for­mer glob­al brand leader of Mer­ck’s an­ti­fun­gal busi­ness, Francesco Maria Lavi­no knows his facts: There are on­ly three class­es of an­ti­fun­gals.

But F2G …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER